Paper37592141
Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis.
Ucar D and 9 others. Rheumatol Int, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis. Papers, record 37592141. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37592141
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Behcet Syndrome | Major topic |
| Uveitis | Major topic |
| Humans | |
| Mycophenolic Acid | |
| Retrospective Studies | |
| Immunosuppressive Agents |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28450313 | Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial. | Ann Rheum Dis | 2017 | https://conductscience.org/library/papers/28450313 | PubMed |
| 2 | 2404204 | A controlled trial of azathioprine in Behçet's syndrome. | N Engl J Med | 1990 | https://conductscience.org/library/papers/2404204 | PubMed |
| 3 | 21699532 | Mycophenolate sodium in the treatment of mucocutaneous Behcet's diseases. | Int J Dermatol | 2011 | https://conductscience.org/library/papers/21699532 | PubMed |
| 4 | 27469583 | Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. | Lancet Respir Med | 2016 | https://conductscience.org/library/papers/27469583 | PubMed |
| 5 | 30107448 | Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations. | Rheumatology (Oxford) | 2018 | https://conductscience.org/library/papers/30107448 | PubMed |
| 6 | 19748676 | Methotrexate for ocular inflammatory diseases. | Ophthalmology | 2009 | https://conductscience.org/library/papers/19748676 | PubMed |
| 7 | 36255985 | Uveitis in Behçet disease - an update. | Curr Opin Rheumatol | 2023 | https://conductscience.org/library/papers/36255985 | PubMed |
| 8 | 20665749 | Azathioprine in severe uveitis of Behçet's disease. | Arthritis Care Res (Hoboken) | 2010 | https://conductscience.org/library/papers/20665749 | PubMed |
| 9 | 33335139 | A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet's syndrome. | Sci Rep | 2020 | https://conductscience.org/library/papers/33335139 | PubMed |
| 10 | 30612116 | Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial. | Ann Rheum Dis | 2019 | https://conductscience.org/library/papers/30612116 | PubMed |
| 11 | 26162757 | Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients. | J Autoimmun | 2015 | https://conductscience.org/library/papers/26162757 | PubMed |
| 12 | 28860798 | Behçet's syndrome: providing integrated care. | J Multidiscip Healthc | 2017 | https://conductscience.org/library/papers/28860798 | PubMed |
| 13 | 30747365 | Phenotypes in Behçet's syndrome. | Intern Emerg Med | 2019 | https://conductscience.org/library/papers/30747365 | PubMed |
| 14 | 36458741 | Current pharmacological solutions for Behçet's syndrome. | Expert Opin Pharmacother | 2023 | https://conductscience.org/library/papers/36458741 | PubMed |
| 15 | 16196117 | Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. | Am J Ophthalmol | 2005 | https://conductscience.org/library/papers/16196117 | PubMed |
| 16 | 19369404 | Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. | J Am Soc Nephrol | 2009 | https://conductscience.org/library/papers/19369404 | PubMed |
| 17 | 29625968 | 2018 update of the EULAR recommendations for the management of Behçet's syndrome. | Ann Rheum Dis | 2018 | https://conductscience.org/library/papers/29625968 | PubMed |
| 18 | 20042178 | Mycophenolate mofetil for ocular inflammation. | Am J Ophthalmol | 2010 | https://conductscience.org/library/papers/20042178 | PubMed |
| 19 | 12544711 | The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. | Medicine (Baltimore) | 2003 | https://conductscience.org/library/papers/12544711 | PubMed |
| 20 | 21968239 | Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet's disease with parenchymal involvement: presentation of four cases. | Clin Exp Rheumatol | 2011 | https://conductscience.org/library/papers/21968239 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41776676 | Upadacitinib for refractory Behcet's syndrome: a multi-centre, single-arm trial. | Arthritis Res Ther | 2026 | https://conductscience.org/library/papers/41776676 | PubMed |
| 41396112 | Can mycophenolate mofetil be an effective option in the treatment of vascular Behçet's Syndrome. | Sarcoidosis Vasc Diffuse Lung Dis | 2025 | https://conductscience.org/library/papers/41396112 | PubMed |
| 40182974 | Behçet syndrome with eye involvement. | Saudi J Ophthalmol | 2025 | https://conductscience.org/library/papers/40182974 | PubMed |
| 37995045 | Disease and Treatment-Specific Complications of Behçet Syndrome. | Curr Rheumatol Rep | 2024 | https://conductscience.org/library/papers/37995045 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37592141
GET https://conductscience.org/api/papers/v1/37592141/references?page=2